Uncommon Therapeutics
A Disease Focused Biotech, Building Multiple Billion Dollar Drugs
Our founder Noah, an experienced tech entrepreneur, was directly impacted by a severe genetic disease when his daughter was diagnosed with Rett Syndrome, a disease that afflicts 1 in 10,000 girls. Using an innovative polytherapy strategy, we’ve successfully improved her quality of life, and have designed new therapeutics that each could be worth billions and together could deliver a cure.
- Website
- uncommontherapeutics.com
- City
- San Francisco
- Country
- United States
- YC batch
- Winter 2025
- Team
- 2 people
- Stage
- Early stage
- AI-native
- No
More Health & bio in San Francisco
Innovaccer$1.3bn
Indian digital healthcare company.
Thatch$1bn
Health benefits. Valued at $1bn (September 2026).
Chan Zuckerberg BiohubLab
Nonprofit research network building virtual cell models.
AthelasHiring
Extensible, Integrated Technology that Simplifies Health Systems
ClipboardHiring
Every shift, Covered.
Benchling
Unlocking the power of biotech with modern software for modern science
Claim this profile
Free and instant: prove you run uncommontherapeutics.com and edit the profile yourself.
- Your logo, office address and founder photos
- The ✓ Verified mark next to Uncommon Therapeutics across the site
- Open roles listed on the Hiring board
- A followed link back to your website
A rank card with Uncommon Therapeutics's standing on Labspie, or a simple badge. Both link to this profile and update themselves.
